ArticleJournal of arrhythmia2026
Sex- and Age-Dependent Outcomes of Cryoablation in Atrial Fibrillation: A 3- and 6-Month Post-Procedural QoL Analysis.
Article in Journal of arrhythmia, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Cryoablation is an established treatment for atrial fibrillation (AF), offering effective rhythm control and symptomatic improvement. However, short-term trajectories of quality-of-life (QoL) recovery-particularly regarding age- and sex-related differences-remain insufficiently characterized. This study evaluated patterns of functional and emotional improvement within 3 and 6 months after cryoablation. Methods: A prospective observational cohort of 150 patients undergoing cryoablation for AF was analyzed. QoL was assessed using the 36-item short form (SF) (Physical and Mental Component Scores PCS and MCS) survey at baseline, 3 months, and 6 months. Results: Significant improvements were observed across all SF-36 (57.5 at baseline to 77.1 at 3-months and 80.1 at 6-months, Conclusions: Cryoablation leads to substantial QoL improvements. While age is a robust independent predictor of recovery, sex-specific differences in physical and emotional trajectories appear as notable trends requiring further investigation. These findings emphasize the need for individualized post-procedural counseling and follow-up tailored to demographic recovery profiles.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.